According to The Fly, in a report released yesterday, Jack Scannell from UBS maintained a Hold rating on AstraZeneca (AZN). The company’s shares closed yesterday at $40.80, close to its 52-week high of $41.78.
The the analyst consensus on AstraZeneca is currently a Moderate Buy rating.
See today’s analyst top recommended stocks >>
AstraZeneca’s market cap is currently $103.1B and has a P/E ratio of 42.29. The company has a Price to Book ratio of 8.67.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
